{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:15:57Z","timestamp":1791530157238,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1053\/j.seminoncol.2023.01.007","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:56:43Z","timestamp":1675357003000},"page":"476-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review"],"prefix":"10.1053","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2004-4644","authenticated-orcid":false,"given":"Irene","family":"Persano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Parlagreco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-8657","authenticated-orcid":false,"given":"Anna","family":"La Salvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Audisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Volante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Buttigliero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-958X","authenticated-orcid":false,"given":"Giorgio Vittorio","family":"Scagliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Brizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.seminoncol.2023.01.007_bib0001","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.suc.2020.02.008","article-title":"Pancreas solid tumors","volume":"100","author":"Younan","year":"2020","journal-title":"Surg Clin North Am"},{"issue":"4","key":"10.1053\/j.seminoncol.2023.01.007_bib0002","article-title":"Incidence and survival patterns of pancreatic neuroendocrine tumors over the last two decades: a SEER database analysis","volume":"38","author":"Sonbol","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.seminoncol.2023.01.007_bib0003","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00428-004-0987-3","article-title":"Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature","volume":"444","author":"Adsay","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0004","first-page":"359","article-title":"Prognostic significance of pancreatic metastases from renal cell carcinoma in patients treated with Tyrosine kinase inhibitors","volume":"38","author":"Chrom","year":"2018","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1053\/j.seminoncol.2023.01.007_bib0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dc.23724","article-title":"Diagnosing clear cell neuroendocrine tumors on cytological specimens: report of two cases and brief literature review","volume":"45","author":"Buckley","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0006","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00261-018-01889-x","article-title":"Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features","volume":"44","author":"van der Pol","year":"2019","journal-title":"Abd Radiol"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1245\/ASO.2006.03.064","article-title":"Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery","volume":"13","author":"Sellner","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0008","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1053\/j.seminoncol.2023.01.007_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAP.0000000000000201","article-title":"Neoplasms of the neuroendocrine pancreas: an update in the classification, definition, and molecular genetic advances","volume":"26","author":"Guilmette","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.seminoncol.2023.01.007_sbref0010","article-title":"Neuroendocrine tumor of the pancreas: statistics","year":"2020","journal-title":"Cancer.Net"},{"issue":"1","key":"10.1053\/j.seminoncol.2023.01.007_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/his.13367","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates","volume":"72","author":"Chai","year":"2018","journal-title":"Histopathology"},{"issue":"1s","key":"10.1053\/j.seminoncol.2023.01.007_bib0012","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/modpathol.3800686","article-title":"Nonductal neoplasms of the pancreas","volume":"20","author":"Klimstra","year":"2007","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.seminoncol.2023.01.007_bib0013","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5946\/ce.2017.131","article-title":"Diagnosis of pancreatic neuroendocrine tumors","volume":"50","author":"Lee","year":"2017","journal-title":"Clin Endosc"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0014","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00261-017-1363-5","article-title":"Hypervascular pancreatic \u2018\u2018lesions\u2019\u2019: a pattern-based approach to differentiation","volume":"43","author":"Shankar","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(09)70065-8","article-title":"The role of surgery in the management of isolated metastases to the pancreas","volume":"10","author":"Reddy","year":"2009","journal-title":"Lancet Oncol"},{"issue":"43","key":"10.1053\/j.seminoncol.2023.01.007_bib0016","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.3748\/wjg.v17.i43.4747","article-title":"Pancreatic metastases from renal cell carcinoma: the state of the art","volume":"17","author":"Ballarin","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1053\/j.seminoncol.2023.01.007_bib0017","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4251\/wjgo.v6.i10.381","article-title":"Metastatic tumors to the pancreas: the role of surgery","volume":"6","author":"Sperti","year":"2014","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2023.01.007_bib0018","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1148\/rg.2018170201","article-title":"Nonepithelial neoplasms of the pancreas, part 2: malignant tumors and tumors of uncertain malignant potential","volume":"38","author":"Manning","year":"2018","journal-title":"Radiographics"},{"issue":"2","key":"10.1053\/j.seminoncol.2023.01.007_bib0019","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0020","first-page":"6074","article-title":"Somatostatin receptors in human renal cell carcinomas","volume":"52","author":"Reubi","year":"1992","journal-title":"Cancer Res"},{"issue":"10","key":"10.1053\/j.seminoncol.2023.01.007_bib0021","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/RLU.0000000000002718","article-title":"68Ga-DOTATATE uptake in pancreatic metastasis of renal cell carcinoma mimicking pancreatic neuroendocrine tumor","volume":"44","author":"Soydal","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2023.01.007_bib0022","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/1097-0142(20000901)89:5<1076::AID-CNCR17>3.0.CO;2-M","article-title":"Renal cell carcinoma to the pancreas in surgical pathology material","volume":"89","author":"Thompson","year":"2000","journal-title":"Cancer"},{"issue":"11","key":"10.1053\/j.seminoncol.2023.01.007_bib0023","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/arpa.2019-0338-RA","article-title":"A clinicopathologic and molecular update of pancreatic neuroendocrine neoplasms with a focus on the new World Health Organization classification","volume":"143","author":"Fang","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0024","first-page":"7","article-title":"Clear cell neuroendocrinetumor of pancreas: endoscopic ultrasound-guided fine needle aspi-ration diagnosis of an uncommon variant","volume":"13","author":"Kaur","year":"2016","journal-title":"Cyto J"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2214\/ajr.155.3.1974734","article-title":"Islet cell tumors in on Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias","volume":"155","author":"Binkovitz","year":"1990","journal-title":"AJR"},{"issue":"283","key":"10.1053\/j.seminoncol.2023.01.007_bib0026","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q J Med"},{"issue":"2","key":"10.1053\/j.seminoncol.2023.01.007_bib0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.soc.2019.11.003","article-title":"Pathologic considerations in gastroenteropancreatic neuroendocrine tumors","volume":"29","author":"Bellizzi","year":"2020","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0028","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00795-017-0167-6","article-title":"Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor","volume":"51","author":"Tanigawa","year":"2018","journal-title":"Med Mol Morphol"},{"issue":"1","key":"10.1053\/j.seminoncol.2023.01.007_bib0029","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5858\/2010-0478-RAR.1","article-title":"Immunohistochemical diagnosis of renal neoplasms","volume":"135","author":"Truong","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1053\/j.seminoncol.2023.01.007_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/PAI.0b013e318257cc1c","article-title":"PAX8 mouse monoclonal antibody [BC12] recognizes a restricted epitope and is highly sensitive in renal cell and ovarian cancers but does not cross-react with B cells and tumors of pancreatic origin","volume":"21","author":"Tacha","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0031","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199609193351207","article-title":"Renal-cell carcinoma","volume":"335","author":"Motzer","year":"1996","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.seminoncol.2023.01.007_bib0032","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0033","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bjs.10312","article-title":"Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms","volume":"104","author":"Partelli","year":"2017","journal-title":"Br J Surg"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0034","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS Consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrclinonc.2016.37","article-title":"Evaluation and management of pancreatic lesions in patients with von Hippel\u2013Lindau disease","volume":"13","author":"Keutgen","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1053\/j.seminoncol.2023.01.007_bib0036","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNET)","volume":"142","author":"Blansfield","year":"2007","journal-title":"Surgery"},{"issue":"9","key":"10.1053\/j.seminoncol.2023.01.007_bib0037","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/ERC-18-0100","article-title":"Preventive medicine of von Hippel\u2013Lindau disease-associated pancreatic neuroendocrine tumors","volume":"25","author":"Krauss","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0038","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2015.65.6140","article-title":"Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome","volume":"34","author":"Nielsen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1053\/j.seminoncol.2023.01.007_bib0039","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2169\/internalmedicine.8347-16","article-title":"Renal cell carcinoma and a pancreatic neuroendocrine tumor: a coincidence or instance of von Hippel-Lindau disease?","volume":"56","author":"Matsubayashi","year":"2017","journal-title":"Intern Med"},{"issue":"2","key":"10.1053\/j.seminoncol.2023.01.007_bib0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.9738\/CC8.1","article-title":"Mixed ductal-endocrine carcinoma of the pancreas occurring as a double cancer: report of a case","volume":"96","author":"Araki","year":"2011","journal-title":"Int Surg"},{"issue":"5","key":"10.1053\/j.seminoncol.2023.01.007_bib0041","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00000478-200105000-00006","article-title":"Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma","volume":"25","author":"Hoang","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.seminoncol.2023.01.007_bib0042","first-page":"83","article-title":"Clear cell neuroendocrine tumor of the pancreas in von Hippel-Lindau disease: a case report and literature review","volume":"38","author":"Woo","year":"2017","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1053\/j.seminoncol.2023.01.007_bib0043","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1100\/tsw.2005.5","article-title":"Metastatic renal cell carcinoma versus pancreatic neuroendocrine tumor in Von Hippel Lindau disease: treatment with Interleukin-2","volume":"5","author":"Williams","year":"2005","journal-title":"Sci World J"},{"issue":"8","key":"10.1053\/j.seminoncol.2023.01.007_bib0044","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijscr.2013.03.004","article-title":"Von Hippel\u2013Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinoma neoplasm: case report and review of the literature","volume":"4","author":"Addeo","year":"2013","journal-title":"Int J Surg Case Rep"},{"issue":"6","key":"10.1053\/j.seminoncol.2023.01.007_bib0045","first-page":"517","article-title":"Sunitinib treatment for multifocal renal cell carcinoma (RCC) and pancreatic neuroendocrine tumor (NET) in patient with von Hippel-Lindau disease. Case report","volume":"36","author":"Babinska","year":"2015","journal-title":"Neuro Endocrinol Lett"},{"issue":"9","key":"10.1053\/j.seminoncol.2023.01.007_bib0046","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/15384047.2018.1470732","article-title":"A retrospective case study of sunitinib treatment in three patients with von Hippel-Lindau disease","volume":"19","author":"Yuan","year":"2018","journal-title":"Cancer Biol Ther"},{"issue":"22","key":"10.1053\/j.seminoncol.2023.01.007_bib0047","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775423000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775423000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:58:02Z","timestamp":1758805082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775423000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0093775423000064"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2023.01.007","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2023.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}